Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling.

Saved in:
Bibliographic Details
Title: Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling.
Authors: Pyo MK; Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea., Park HS; Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea., Ko JH; Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea., Lim DS; Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea., Gwon HJ; Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea., Abd El-Aty AM; Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt; Department of Medical Pharmacology, Medical Faculty, Ataturk University, Erzurum, 25240, Turkey., Yağan R; Department of Anatomy, Faculty of Medicine. Ataturk University, Erzurum, 25240, Turkey., Song JH; Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea., Shin YK; Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea., Jeong JH; Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea. Electronic address: jhjeong@cau.ac.kr., Jung TW; Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Electronic address: twjung@cau.ac.kr.
Source: Archives of biochemistry and biophysics [Arch Biochem Biophys] 2026 Jul; Vol. 781, pp. 110820. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0384 (Electronic) Linking ISSN: 00039861 NLM ISO Abbreviation: Arch Biochem Biophys Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-0384
DOI:10.1016/j.abb.2026.110820